# QMS Supply Chain OS - Final Deliverable Outline

## Presentation Structure (PPT/Document)

---

### Slide 1: Title Slide
**Title**: Understanding QMS Modules in Life Sciences Supply Chain OS

**Subtitle**: A Comprehensive Analysis of Quality Management Systems

**Your Name**: [Your Name]

**Date**: [Date]

---

### Slide 2: Table of Contents
1. Introduction to QMS
2. Platform Overview
3. In-Process Quality Modules
   - Deviation Management
   - CAPA
4. In-Product Quality Modules
   - Product Complaints
   - Recall Management
   - Adverse Event Reporting
5. QMS Management
   - Supplier Management
6. Role-Based Perspectives
7. Integration & Workflows
8. Real-World Examples
9. Conclusion

---

### Slide 3: Introduction to QMS
**What is Quality Management System (QMS)?**
- Definition and importance in Life Sciences
- Regulatory requirements (FDA, EMA, ICH)
- Role in ensuring product quality and patient safety

**Key Components**:
- Quality Control
- Quality Assurance
- Continuous Improvement
- Compliance Management

---

### Slide 4: Platform Overview
**Supply Chain OS - Quality Module**

**URL**: http://216.48.184.249:5274/quality

**Key Features**:
- Integrated quality management
- Real-time tracking and monitoring
- Compliance documentation
- Role-based access control

**Target Users**:
- Quality Executives / QA Officers
- Production Managers
- Regulatory Affairs
- Supply Chain Managers

---

## SECTION 1: IN-PROCESS QUALITY

---

### Slide 5: Deviation Management - Overview
**Purpose**: Track and manage deviations from standard operating procedures

**When Used**:
- Manufacturing process deviations
- Equipment malfunctions
- Procedure non-compliance
- Environmental excursions

**Key Stakeholders**:
- Production Manager (Reports)
- QA Officer (Investigates)
- Quality Manager (Approves)

---

### Slide 6: Deviation Management - Workflow
**[INSERT FLOWCHART HERE]**

**Process Flow**:
1. Deviation Detected
2. Deviation Reported
3. Initial Assessment
4. Investigation
5. Root Cause Analysis
6. Corrective Action (if needed)
7. Closure & Documentation

---

### Slide 7: Deviation Management - API Example
**Scenario**: Temperature Deviation During API Synthesis

**Details**:
- **Product**: Ibuprofen API
- **Deviation**: Reactor temperature exceeded specification (85°C vs 80°C max)
- **Duration**: 15 minutes
- **Batch**: API-2024-001

**Impact Assessment**:
- Potential impact on API purity
- Risk of impurity formation

**Actions Taken**:
1. Batch placed on hold
2. Additional testing performed
3. Root cause: Temperature controller malfunction
4. CAPA initiated for equipment maintenance

**Outcome**: Batch released after testing confirmed compliance

---

### Slide 8: Deviation Management - Raw Material Example
**Scenario**: Raw Material Storage Temperature Deviation

**Details**:
- **Material**: Lactose Monohydrate (excipient)
- **Deviation**: Cold storage temperature rose to 28°C (spec: 2-8°C)
- **Duration**: 2 hours (power outage)
- **Lot**: RM-LAC-2024-045

**Impact Assessment**:
- Potential moisture absorption
- Stability concerns

**Actions Taken**:
1. Material quarantined
2. Moisture content testing
3. Stability study initiated
4. CAPA for backup power system

**Outcome**: Material rejected, supplier notified

---

### Slide 9: Deviation Management - Role Perspectives

**QA Officer Perspective**:
- **Responsibilities**:
  - Investigate deviations
  - Determine impact on product quality
  - Approve/reject batches
  - Ensure regulatory compliance
- **Daily Activities**:
  - Review new deviation reports
  - Conduct root cause analysis
  - Coordinate with production
  - Document findings

**Production Manager Perspective**:
- **Responsibilities**:
  - Report deviations immediately
  - Implement corrective actions
  - Prevent recurrence
  - Maintain production records
- **Daily Activities**:
  - Monitor process parameters
  - Document any deviations
  - Coordinate with QA
  - Implement process improvements

---

### Slide 10: CAPA - Overview
**Purpose**: Systematic approach to identify, correct, and prevent quality issues

**Types**:
- **Corrective Action**: Fix existing problems
- **Preventive Action**: Prevent potential problems

**Triggers**:
- Deviations
- Audit findings
- Customer complaints
- Trend analysis
- Risk assessments

---

### Slide 11: CAPA - Workflow
**[INSERT FLOWCHART HERE]**

**Process Flow**:
1. Problem Identification
2. CAPA Initiation
3. Root Cause Analysis (5 Why's, Fishbone)
4. Action Plan Development
5. Implementation
6. Effectiveness Verification
7. Closure

---

### Slide 12: CAPA - API Example
**Scenario**: Recurring API Batch Failures

**Problem Statement**:
- 3 out of 10 batches of Paracetamol API failed purity testing
- Impurity levels exceeded specification
- Trend observed over 2 months

**Root Cause Analysis**:
- **Why 1**: Why did batches fail? → Impurity levels too high
- **Why 2**: Why were impurity levels high? → Reaction time insufficient
- **Why 3**: Why was reaction time insufficient? → Operator error in timing
- **Why 4**: Why did operator make errors? → Lack of clear SOPs
- **Why 5**: Why were SOPs unclear? → Recent process change not documented

**Corrective Actions**:
1. Update SOPs with new process parameters
2. Retrain all operators
3. Implement automated timing controls

**Preventive Actions**:
1. SOP review process for all changes
2. Automated process monitoring
3. Regular operator competency assessments

**Effectiveness Check**: Monitor next 20 batches → All passed

---

### Slide 13: CAPA - Raw Material Example
**Scenario**: Supplier Quality Issues

**Problem Statement**:
- Magnesium Stearate from Supplier X consistently fails particle size testing
- 5 lots rejected in 3 months
- Production delays due to material shortages

**Root Cause Analysis**:
- Supplier changed milling equipment
- New equipment produces inconsistent particle size
- Supplier did not notify customer of change

**Corrective Actions**:
1. Reject all affected lots
2. Supplier audit conducted
3. Supplier implements process controls
4. Enhanced incoming inspection

**Preventive Actions**:
1. Supplier change notification requirement in contract
2. Dual sourcing strategy
3. Quarterly supplier performance reviews
4. Risk-based supplier monitoring

**Effectiveness Check**: Next 10 lots all passed specifications

---

## SECTION 2: IN-PRODUCT QUALITY

---

### Slide 14: Product Complaints - Overview
**Purpose**: Manage and investigate customer complaints about products

**Types of Complaints**:
- Quality defects
- Packaging issues
- Labeling errors
- Efficacy concerns
- Adverse events

**Importance**:
- Patient safety
- Regulatory compliance
- Brand reputation
- Continuous improvement

---

### Slide 15: Product Complaints - Workflow
**[INSERT FLOWCHART HERE]**

**Process Flow**:
1. Complaint Received
2. Complaint Logged
3. Initial Assessment
4. Investigation
5. Root Cause Determination
6. Customer Response
7. CAPA (if needed)
8. Closure

---

### Slide 16: Product Complaints - API Example
**Scenario**: Complaint About API Discoloration

**Complaint Details**:
- **Customer**: Pharmaceutical Manufacturer XYZ
- **Product**: Aspirin API
- **Batch**: API-ASP-2024-089
- **Issue**: API has slight yellow tint instead of white
- **Quantity**: 500 kg

**Investigation**:
1. Retain sample analysis → Confirmed discoloration
2. Batch record review → No deviations noted
3. Stability data review → Within specification
4. Impurity testing → Trace iron detected

**Root Cause**: Iron contamination from reactor cleaning residue

**Actions**:
1. Batch recalled
2. Reactor cleaning procedure revised
3. CAPA for equipment cleaning validation
4. Customer compensated

---

### Slide 17: Product Complaints - Raw Material Example
**Scenario**: Complaint About Gelatin Capsule Brittleness

**Complaint Details**:
- **Customer**: Consumer
- **Product**: Vitamin D Capsules
- **Batch**: CAP-VD-2024-123
- **Issue**: Capsules breaking easily
- **Quantity**: 1 bottle (60 capsules)

**Investigation**:
1. Retain sample testing → Confirmed brittleness
2. Gelatin supplier investigation → Low moisture content
3. Storage condition review → Humidity too low
4. Other batches checked → Same issue in 3 batches

**Root Cause**: Storage in low humidity environment

**Actions**:
1. Affected batches recalled
2. Storage conditions corrected
3. Packaging improved (moisture barrier)
4. CAPA for environmental monitoring

---

### Slide 18: Recall Management - Overview
**Purpose**: Systematically remove defective products from the market

**Recall Classifications** (FDA):
- **Class I**: Serious health hazard or death
- **Class II**: Temporary health problem
- **Class III**: Unlikely to cause health problem

**Triggers**:
- Product defects
- Contamination
- Labeling errors
- Stability failures
- Regulatory requirements

---

### Slide 19: Recall Management - Workflow
**[INSERT FLOWCHART HERE]**

**Process Flow**:
1. Recall Decision
2. Recall Classification
3. Scope Determination
4. Regulatory Notification
5. Customer/Public Notification
6. Product Retrieval
7. Effectiveness Verification
8. Final Report

---

### Slide 20: Recall Management - API Example
**Scenario**: API Recall Due to Microbial Contamination

**Recall Details**:
- **Product**: Cephalexin API
- **Reason**: Microbial contamination detected
- **Classification**: Class II
- **Scope**: 3 batches (1,500 kg total)
- **Distribution**: 5 pharmaceutical manufacturers

**Timeline**:
- **Day 1**: Contamination detected in stability testing
- **Day 2**: Recall decision made, regulatory notification
- **Day 3**: Customer notification sent
- **Day 7**: 95% product retrieved
- **Day 14**: 100% product retrieved
- **Day 30**: Final recall report submitted

**Root Cause**: Sterile filtration failure

**Actions**:
1. All affected batches destroyed
2. Filtration system validated
3. Enhanced microbial monitoring
4. CAPA for sterilization process

---

### Slide 21: Recall Management - Raw Material Example
**Scenario**: Excipient Recall Due to Labeling Error

**Recall Details**:
- **Product**: Microcrystalline Cellulose
- **Reason**: Incorrect lot number on label
- **Classification**: Class III
- **Scope**: 1 batch (500 kg)
- **Distribution**: 2 customers

**Timeline**:
- **Day 1**: Labeling error discovered
- **Day 1**: Customers notified
- **Day 3**: Product retrieved
- **Day 7**: Relabeling completed
- **Day 10**: Product redistributed

**Root Cause**: Label printer malfunction

**Actions**:
1. Product relabeled and released
2. Label verification procedure enhanced
3. CAPA for labeling equipment maintenance

---

### Slide 22: Adverse Event Reporting - Overview
**Purpose**: Report and track adverse events related to pharmaceutical products

**Types of Adverse Events**:
- Serious Adverse Events (SAE)
- Non-serious Adverse Events
- Medication Errors
- Product Quality Issues

**Regulatory Requirements**:
- FDA: 15-day and periodic reports
- EMA: Similar requirements
- Pharmacovigilance obligations

---

### Slide 23: Adverse Event Reporting - Workflow
**[INSERT FLOWCHART HERE]**

**Process Flow**:
1. Event Reported
2. Event Logged
3. Severity Assessment
4. Causality Assessment
5. Investigation
6. Regulatory Reporting
7. Follow-up
8. Closure

---

### Slide 24: Adverse Event Reporting - API Example
**Scenario**: Serious Adverse Event with Antibiotic API

**Event Details**:
- **Product**: Amoxicillin tablets
- **Event**: Severe allergic reaction (anaphylaxis)
- **Patient**: 45-year-old female
- **Outcome**: Hospitalized, recovered
- **Batch**: AMX-2024-067

**Causality Assessment**:
- **Probable**: Patient has penicillin allergy (not disclosed)
- **Product Quality**: Batch testing confirmed compliance

**Actions**:
1. Immediate regulatory report (15-day)
2. Batch investigation (no quality issues found)
3. Label review (allergy warning adequate)
4. No recall needed
5. Case documented in pharmacovigilance database

---

### Slide 25: Adverse Event Reporting - Raw Material Example
**Scenario**: Adverse Event Linked to Excipient

**Event Details**:
- **Product**: Multivitamin tablets
- **Event**: Gastrointestinal distress
- **Patients**: Multiple reports (15 cases)
- **Common Factor**: Same batch
- **Batch**: MV-2024-234

**Investigation**:
1. Batch testing → All within specification
2. Excipient review → Titanium dioxide from new supplier
3. Literature review → Some sensitivity to TiO2 reported

**Causality Assessment**:
- **Possible**: May be related to excipient source

**Actions**:
1. Regulatory notification
2. Batch recall (voluntary, Class III)
3. Excipient supplier changed
4. Enhanced excipient testing

---

## SECTION 3: QMS MANAGEMENT

---

### Slide 26: Supplier Management - Overview
**Purpose**: Ensure suppliers meet quality standards and regulatory requirements

**Key Activities**:
- Supplier qualification
- Supplier audits
- Performance monitoring
- Risk assessment
- CAPA management

**Importance**:
- Supply chain quality
- Regulatory compliance
- Risk mitigation
- Cost management

---

### Slide 27: Supplier Management - Workflow
**[INSERT FLOWCHART HERE]**

**Process Flow**:
1. Supplier Identification
2. Initial Assessment
3. Qualification Audit
4. Approval
5. Ongoing Monitoring
6. Periodic Re-qualification
7. Performance Review
8. CAPA (if needed)

---

### Slide 28: Supplier Management - API Example
**Scenario**: Qualification of New API Supplier

**Supplier Details**:
- **Company**: ABC Pharmaceuticals Ltd.
- **Product**: Metformin API
- **Location**: India
- **Capacity**: 100 MT/year

**Qualification Process**:
1. **Initial Assessment**:
   - Regulatory status (GMP certified)
   - Financial stability
   - Technical capability
   - References checked

2. **Audit**:
   - On-site audit conducted
   - Manufacturing process reviewed
   - Quality system evaluated
   - Minor findings noted

3. **Trial Order**:
   - 100 kg trial batch ordered
   - Full testing performed
   - Stability study initiated

4. **Approval**:
   - Supplier approved
   - Annual audit scheduled
   - Performance metrics defined

---

### Slide 29: Supplier Management - Raw Material Example
**Scenario**: Supplier Performance Monitoring

**Supplier Details**:
- **Company**: XYZ Chemicals
- **Product**: Lactose Monohydrate
- **Relationship**: 5 years

**Performance Metrics** (Last 12 months):
- **Quality**: 95% acceptance rate (target: 98%)
- **Delivery**: 85% on-time (target: 95%)
- **Documentation**: 90% complete (target: 100%)

**Issues Identified**:
- 3 lots rejected for particle size
- 2 late deliveries
- Missing COAs on 2 shipments

**Actions**:
1. Supplier meeting scheduled
2. CAPA initiated
3. Enhanced incoming inspection
4. Backup supplier identified

**Outcome**: Performance improved to target levels

---

## SECTION 4: INTEGRATION & ROLE PERSPECTIVES

---

### Slide 30: Module Integration
**[INSERT INTEGRATION FLOWCHART HERE]**

**How Modules Connect**:

```
Deviation → CAPA → Product Complaint → Recall
     ↓         ↓            ↓             ↓
  Supplier  Supplier    Adverse      Regulatory
  Management Management  Events       Reporting
```

**Example Integration Flow**:
1. Deviation detected in production
2. CAPA initiated to prevent recurrence
3. If customer impacted → Product Complaint
4. If widespread → Recall Management
5. If patient harm → Adverse Event Reporting
6. If supplier-related → Supplier Management

---

### Slide 31: QA Officer - Daily Workflow
**Typical Day**:

**Morning**:
- Review overnight deviation reports
- Prioritize investigations
- Assign tasks to team

**Midday**:
- Conduct deviation investigations
- Review CAPA effectiveness
- Approve batch releases

**Afternoon**:
- Respond to product complaints
- Coordinate with regulatory
- Update documentation

**Key Responsibilities**:
- Ensure product quality
- Maintain compliance
- Investigate issues
- Approve/reject decisions

---

### Slide 32: Production Manager - Daily Workflow
**Typical Day**:

**Morning**:
- Review production schedule
- Check equipment status
- Brief production team

**Midday**:
- Monitor production processes
- Address any deviations
- Coordinate with QA

**Afternoon**:
- Review batch records
- Implement CAPAs
- Plan next day's production

**Key Responsibilities**:
- Maintain production quality
- Report deviations
- Implement improvements
- Coordinate with QA

---

### Slide 33: SME Context - Quality in Small & Medium Enterprises

**Challenges for SMEs**:
- Limited resources
- Smaller teams (QA Officer may wear multiple hats)
- Cost constraints
- Regulatory pressure

**How QMS Helps SMEs**:
- **Efficiency**: Streamlined processes
- **Compliance**: Automated documentation
- **Cost Savings**: Prevent quality issues
- **Scalability**: Grow without quality compromise

**Real-World SME Scenario**:
- Small API manufacturer (50 employees)
- 1 QA Officer, 2 Production Managers
- Using QMS to manage 200+ deviations/year
- Reduced CAPA cycle time by 40%
- Improved supplier quality by 25%

---

### Slide 34: Key Insights & Learnings

**What I Learned**:
1. **Integration is Critical**: Modules don't work in isolation
2. **Roles are Interconnected**: QA and Production must collaborate
3. **Documentation is Essential**: Every action must be traceable
4. **Prevention > Correction**: Preventive actions save time and money
5. **Supplier Quality Matters**: Supply chain quality impacts product quality

**Real-World Application**:
- QMS is not just software, it's a mindset
- Quality culture starts with leadership
- Continuous improvement is ongoing
- Patient safety is paramount

---

### Slide 35: Conclusion

**Summary**:
- Explored 6 QMS modules in depth
- Understood end-to-end workflows
- Analyzed API and Raw Material examples
- Examined role-based perspectives
- Identified integration points

**Key Takeaways**:
1. QMS is essential for Life Sciences quality
2. Each module serves a specific purpose
3. Integration ensures comprehensive quality management
4. Roles must collaborate for success
5. Continuous improvement is the goal

**Thank You!**

---

## Appendix Slides

### Appendix A: Glossary
- **API**: Active Pharmaceutical Ingredient
- **CAPA**: Corrective and Preventive Action
- **GMP**: Good Manufacturing Practice
- **QA**: Quality Assurance
- **QC**: Quality Control
- **SOP**: Standard Operating Procedure
- **COA**: Certificate of Analysis

### Appendix B: Regulatory References
- FDA 21 CFR Part 211 (GMP)
- ICH Q10 (Pharmaceutical Quality System)
- ISO 9001 (Quality Management)

### Appendix C: Screenshots
[Include all captured screenshots from exploration]

---

## Presentation Tips

1. **Keep slides visual**: Use flowcharts, diagrams, and screenshots
2. **Tell stories**: Use real-world examples
3. **Be concise**: Don't overcrowd slides
4. **Practice**: Rehearse your presentation
5. **Engage**: Ask questions, encourage discussion
6. **Show understanding**: Demonstrate you truly understand the workflows

---

## Deliverable Checklist

- [ ] PowerPoint presentation (35+ slides)
- [ ] Flowcharts for all 6 modules
- [ ] API examples for each module
- [ ] Raw Material examples for each module
- [ ] Role-based perspectives documented
- [ ] Integration diagram
- [ ] Screenshots from platform
- [ ] Glossary and references
- [ ] Practice presentation

---

**Remember**: The goal is to demonstrate your UNDERSTANDING, not just create slides. Make sure you can explain each workflow, give examples, and discuss role perspectives fluently!
